Precision and Future Medicine (Sep 2021)

Monogenic diabetes mellitus and clinical implications of genetic diagnosis

  • Eungu Kang,
  • Lindsey Yoojin Chung,
  • Yu Jin Kim,
  • Kyung Eun Oh,
  • Young-Jun Rhie

DOI
https://doi.org/10.23838/pfm.2021.00100
Journal volume & issue
Vol. 5, no. 3
pp. 106 – 116

Abstract

Read online

Monogenic diabetes mellitus, which is diabetes caused by a defect in a single gene that is associated with β cell function or insulin action, accounts for 1% to 6% of all pediatric diabetes cases. Accurate diagnosis is important, as the effective treatment differs according to genetic etiology in some types of monogenic diabetes: high-dose sulfonylurea treatment in neonatal diabetes caused by activating mutations in KCNJ11 or ABCC8; low-dose sulfonylurea treatment in HNF1A/HNF4A-diabetes; and no treatment in GCK diabetes. Monogenic diabetes should be suspected by clinicians for certain combinations of clinical features and laboratory results, and approximately 80% of monogenic diabetes cases are misdiagnosed as type 1 diabetes or type 2 diabetes. Here, we outline the types of monogenic diabetes and the clinical implications of genetic diagnosis.

Keywords